Product Information
PROCTOFOAM 1% FOAM is a brand product labeled by Viatris Specialty LLC, priced at $7.1734 per GM under NDC 00037682315. Its NADAC has been published 93 times since Sep 18, 2024.
Strength
150 mg/15g
Manufacturer
Viatris Specialty LLCNDC
00037682315
Classification
Brand
Dosage Form
AEROSOL, FOAM
Route
RECTAL
Last Updated
6/17/2026
Active Ingredients
PRAMOXINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M346On Market Since
8/18/2014
Price Statistics
The NADAC for PROCTOFOAM 1% FOAM has been published 93 times since Sep 18, 2024, and over the history we have for it it has risen 22.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $7.1734 per GM |
|---|---|
| All-time high | $7.1734 (Jun 24, 2026) |
| All-time low | $5.8764 (Sep 18, 2024) |
| 52-week high | $7.1734 |
| 52-week low | $6.0131 |
| Median price | $6.3054 |
| Average price | $6.3259 |
| Largest weekly change | +8.6% (Jun 17, 2026) |
| Weeks tracked | 93 |
| Tracking since | Sep 18, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the pramoxine hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of PROCTOFOAM 1% FOAM?
The current National Average Drug Acquisition Cost (NADAC) for PROCTOFOAM 1% FOAM, manufactured by Viatris Specialty LLC, is $7.1734 per GM (NDC 00037682315), effective Jun 24, 2026.
How has the price of PROCTOFOAM 1% FOAM changed over time?
Over the history we have for it, the NADAC for PROCTOFOAM 1% FOAM has risen 22.1%. It has been tracked across 93 weekly CMS publications since Sep 18, 2024.
What are the highest and lowest recorded NADAC prices for PROCTOFOAM 1% FOAM?
Since Sep 18, 2024, the NADAC for PROCTOFOAM 1% FOAM has ranged from a low of $5.8764 (Sep 18, 2024) to a high of $7.1734 (Jun 24, 2026), with a median of $6.3054 per GM.
Are there cheaper alternatives to PROCTOFOAM 1% FOAM?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of PROCTOFOAM 1% FOAM, so no direct lower-cost alternative is listed.
Who manufactures PROCTOFOAM 1% FOAM?
PROCTOFOAM 1% FOAM (NDC 00037682315) is labeled by Viatris Specialty LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification